Di Martino Giuseppe, Mazzocca Riccardo, Masci Tania, Berghella Lisa, Del Papa Jacopo, D'Aloisio Francesco, Messinese Mario, Cedrone Fabrizio, Marani Toro Patrizia, Soldato Graziella
Unit of Epidemiology and Health Statistics, Local Health Authority of Pescara, 65100 Pescara, Italy.
Department of Medicine and Ageing Sciences, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.
Vaccines (Basel). 2025 Jan 28;13(2):138. doi: 10.3390/vaccines13020138.
Splenectomized patients have a higher risk compared to the general population of developing post-splenectomy infection, particularly by capsulated bacteria. Splenectomized patients need to be vaccinated against pneumococcal diseases, meningococcal disease, and heamophilus influenzae (Hib) in order to avoid invasive bacterial diseases. This study evaluated vaccination coverages among splenectomized patients in a Southern Italian province.
A retrospective study was conducted evaluating all splenectomized patients from the Pescara province from 2015 to 2023. Vaccination coverages were calculated before and after splenectomy for the following vaccines: pneumococcal disease, meningococcal disease, Hib, and COVID-19.
A total of 97 patients were considered during the study period. Vaccination coverages were low before surgery, but they increased after splenectomy. Higher coverages were found against pneumococcal diseases (77.3%), meninigococcal disease (58.8%), and COVID-19 (91.8%).
Vaccination coverages among splenectomized patients in the Pescara province are not satisfying. It is imperative to implement educational measures for patients and physicians to increase vaccination coverages.
与普通人群相比，脾切除患者发生脾切除术后感染的风险更高，尤其是由包膜细菌引起的感染。脾切除患者需要接种肺炎球菌疾病、脑膜炎球菌疾病和流感嗜血杆菌（Hib）疫苗，以避免侵袭性细菌疾病。本研究评估了意大利南部一个省份脾切除患者的疫苗接种覆盖率。
进行了一项回顾性研究，评估了2015年至2023年佩斯卡拉省所有脾切除患者。计算了脾切除术前和术后以下疫苗的接种覆盖率：肺炎球菌疾病、脑膜炎球菌疾病、Hib和新冠病毒。
研究期间共纳入97例患者。手术前疫苗接种覆盖率较低，但脾切除术后有所增加。肺炎球菌疾病（77.3%）、脑膜炎球菌疾病（58.8%）和新冠病毒（91.8%）的接种覆盖率较高。
佩斯卡拉省脾切除患者的疫苗接种覆盖率不尽人意。必须对患者和医生实施教育措施，以提高疫苗接种覆盖率。
Zotero 插件